Why Mid-Size Health Systems Need Their Own AI Governance Model

AI is moving rapidly into healthcare, from clinical decision support and documentation to patient engagement, revenue cycle, analytics, and operational automation.

For healthcare executives, the question is no longer simply where AI can be used. It is how to adopt it in a way that is safe, accountable, compliant, measurable, and scalable.

For mid-size U.S. health systems, this creates a particular challenge.

A governance model designed for a much larger organization can introduce unnecessary complexity. At the same time, a lightweight approach can leave important questions around privacy, security, clinical risk, vendor accountability, and ROI unanswered.

The answer is not less governance.

It is right-sized AI governance.

AI Governance Should Fit the Organization

AI governance should reflect the organization's:

• Risk exposure

• AI maturity

• Technology environment

• Available resources

• Clinical and operational priorities

• Regulatory and contractual obligations

A practical governance model should provide enough oversight to protect patients and the organization without creating an approval process that becomes disconnected from how teams actually work.

For a healthcare CXO, the goal is straightforward:

Enable responsible AI adoption without creating unnecessary friction.

The Challenge Is Often the AI Vendor, Not the AI Model

Many healthcare organizations will use AI capabilities embedded within third-party products rather than develop every AI model internally.

Instead of asking only: How was this model built?

leaders also need to ask:

What happens to our data?

How is the solution evaluated?

What happens when performance changes?

Who is accountable after deployment?

How are incidents handled?

What evidence supports the vendor's claims?

Vendor governance therefore needs to be part of the AI lifecycle, not an administrative exercise completed before procurement.

Not Every AI Use Case Requires the Same Level of Oversight

A scheduling assistant and a system that materially influences clinical decisions should not go through identical governance processes.

A practical approach is to classify AI use cases according to factors such as:

• Potential impact on patient safety

• Clinical influence

• Sensitivity of the data involved

• Privacy and security exposure

• Regulatory considerations

• Financial or operational impact

• Degree of human oversight

Lower-risk applications can follow a lighter review process. Higher-risk applications should receive deeper evaluation, stronger controls, and more rigorous monitoring.

This risk-based approach is consistent with the philosophy of the NIST AI Risk Management Framework, which is designed to help organizations manage AI risks across the lifecycle and can be applied flexibly according to organizational context.

Clinical AI Requires a Different Level of Attention

The distinction becomes especially important when AI influences diagnosis, treatment, or other clinical decisions.

Some AI-enabled healthcare products may fall within FDA regulated medical device frameworks depending on their intended use and functionality. The FDA continues to develop and update guidance around AI enabled medical devices, including lifecycle management, transparency, and change management.

For healthcare leaders, this means AI governance cannot be separated from the intended use of the technology.

The same governance approach should not automatically be applied to an administrative productivity tool and a clinical AI application.

Governance Needs Clear Ownership

Mid-size health systems don't necessarily need a large standalone AI governance organization. They need clear accountability.

Leadership should establish who is responsible for:

• AI approval

• Risk assessment

• Vendor evaluation

• Data and security review

• Clinical oversight where applicable

• Deployment

• Performance monitoring

• Incident management

• Periodic reassessment

• Retirement of the AI system

The people involved may come from existing functions such as IT, clinical leadership, cybersecurity, compliance, legal, data, and operations.

What matters most is that responsibilities are explicit and decisions are documented.

Governance Doesn't End at Go-Live

One of the biggest mistakes organizations can make is treating AI governance as an approval gate. Approval is only the beginning.

Once an AI system is deployed, organizations need to understand whether it continues to perform as expected and whether its use is producing the intended outcomes.

Depending on the use case, monitoring may include:

Performance → Accuracy → Safety → Security → User feedback → Incidents → Business outcomes

This lifecycle perspective is particularly important for AI systems because models, data, workflows, and usage patterns can change over time.

NIST frames AI risk management as an ongoing activity spanning design, development, deployment, use, testing, and evaluation.

The FDA similarly emphasizes lifecycle considerations for AI-enabled medical devices, including monitoring and managing changes where applicable.

Governance Must Support ROI, Not Just Risk Management

For a healthcare CXO, responsible AI adoption cannot be measured only by whether a policy exists.

Leadership also needs to understand:

• Is the solution delivering the expected business value?

• Are clinicians actually using it?

• Is it improving workflow efficiency?

• Is it reducing administrative burden?

• Is the patient experience improving?

• Are the expected outcomes being sustained?

• Should the organization scale, modify, or retire the solution?

This makes AI governance both a risk-management function and a portfolio-management function.

Good governance should help leadership decide where to invest more, where to improve, and where to stop.

A Practical AI Governance Framework

A mid-size health system can begin with a straightforward lifecycle:

1. Inventory

Identify AI already being used or planned across clinical, operational, administrative, and technology functions including AI capabilities embedded within third-party platforms.

2. Classify

Assess each use case according to its clinical, privacy, security, regulatory, financial, and operational risk.

3. Evaluate

Review the technology, vendor, data flows, security controls, intended use, human oversight, and expected outcomes.

4. Approve

Establish the appropriate approval path based on the risk and use case.

5. Monitor

Track performance, incidents, user feedback, compliance, and business outcomes after deployment.

6. Reassess

Review the AI system as its use, technology, data, risk profile, or regulatory environment changes.

This does not need to become a heavy administrative process.

The objective is to create a repeatable decision-making system that grows with the organization's AI maturity.

The CXO Perspective: Governance as an Enabler

AI governance is sometimes viewed as a barrier to innovation. It doesn't have to be.

A well-designed governance model can actually make AI adoption easier to scale.

• When leadership knows:

• What AI is being used

• Where it is being used

• Who owns it

• What risks it carries

• How vendors are being evaluated

• How performance is monitored

• What value it is generating

decisions become easier.

The organization can move from individual AI experiments to a managed AI portfolio.

That is the real objective of AI governance.

The Right Model Is Proportionate, Not Complicated

Mid-size U.S. health systems don't need to replicate the governance structure of a much larger organization.

They need a model designed around their own:

Risk. Resources. Technology. Clinical priorities. AI maturity.

The right model should be strong enough to protect the organization and flexible enough to support innovation.

It should give executives visibility without creating unnecessary bureaucracy.

And most importantly, it should make responsible AI adoption a repeatable organizational capability rather than a collection of one-off decisions.

Building a Responsible AI Foundation

AI will continue to become part of how healthcare organizations operate, deliver care, engage patients, and make decisions.

The organizations that benefit most will not necessarily be those that adopt AI the fastest.

They will be those that can adopt, evaluate, govern, and scale AI responsibly.

Softnotions helps healthcare organizations build the technology and data foundations required for responsible AI adoption including AI engineering, data engineering, digital platforms, integration, cloud, and healthcare technology solutions.

The goal is not to slow AI adoption, It is to give healthcare leaders the confidence and control to scale it responsibly.